COVID-19: An advisory for a Radiation Oncology Department Pertinent to the Multidisciplinary Team

Kaustav Talapatra; Dipanjan Majumder; Sarbani Ghosh Laskar

doi:10.4103/ijmpo.ijmpo_273_20

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(05): 629-633
DOI: 10.4103/ijmpo.ijmpo_273_20

Editorial Commentary

COVID-19: An advisory for a Radiation Oncology Department Pertinent to the Multidisciplinary Team

Kaustav Talapatra

Department of Radiation Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India

,

Dipanjan Majumder

Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India

,

Sarbani Ghosh Laskar

Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

› Author Affiliations

Abstract

Full Text

References

References
1 Patil V, Noronha V, Chaturvedi P, Talapatra K, Joshi A, Menon N. et al. COVID-19 and head and neck cancer treatment. Cancer Res Stat Treat 2020; 3: 15-28
2 Yu J, Ouyang W, Chua ML, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Onco 2020; 6: 1108-10
3 Mohler JL, Antonarakis ES. NCCN guidelines updates: Management of prostate cancer. J Natl Compr Canc Netw 2019; 17: 583-6
4 https://www.nice.org.uk/guidance/ng162/resources/covid19-rapid-guideline-delivery-of-radiotherapy-pdf-66141897390277. Available from: [Last accessed on 2020 Apr 16].
5 Clinical Guide for the Management of Cancer Patients during the Coronavirus Pandemic. NHS Approval ref no. 001559; 17th March 2020
6 Tchelebi LT, Haustermans K, Scorsetti M, Hosni A, Huguet F, Hawkins MA. et al. Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19. Radiother Oncol 2020; 148: 194-200
7 Gay HA, Santiago R, Gil B, Remedios C, Montes PJ, López-Araujo J. et al. Lessons learned from Hurricane Maria in Puerto Rico: Practical measures to mitigate the impact of a catastrophic natural disaster on radiation oncology patients. Pract Radiat Oncol 2019; 9: 305-21
8 Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM. PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial. Lancet Oncol 2015; 16: 266-73
9 Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J. et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 2015; 16: 47-56
10 Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ. et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013; 14: 1086-94
11 Brunt AM, Haviland J, Sydenham M, Algurafi H, Alhasso A, Bliss P. et al. FAST Phase III RCT of radiotherapy hypofractionation for treatment of early breast cancer: 10-Year Results (CRUKE/04/015). Int J Radiat Oncol Biol Phys 2018; 102: 1603-4
12 Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A. et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol 2016; 120: 114-8
13 Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A. et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005; 27: 843-50
14 Chandarana MN, Pai PS. Demography and treatment pattern of patients with head and neck carcinoma presenting to a tertiary care center in India: Need for urgent decentralization of cancer care. South Asian J Cancer 2020; 9: 38-42
15 Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F. et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial. J Clin Oncol 2003; 21: 327-33
16 Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E. et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): An open-label, phase 2, randomised trial. Lancet Oncol 2019; 20: 1349-59
17 Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codecà C. et al. Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial. Ann Oncol 2017; 28: 2206-12
18 Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Arya S. et al. Weekly chemotherapy as induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy. Indian J Cancer 2014; 51: 20-4
19 Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J. et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: A multicentre, randomised, open-label, phase 3 trial. Lancet 2016; 388: 1883-92
20 Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA. et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radia Oncol 2020;
21 https://uroweb.org/covid-19-recommendations-by-eau-guidelines-panels/. Available from: [Last accessed on 2020 Jun 04]